$991 Million is the total value of HARVARD MANAGEMENT CO INC's 44 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 13.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FB | Buy | META PLATFORMS INCcl a | $273,729,000 | +118.7% | 1,231,019 | +230.8% | 27.63% | +135.2% |
GOOGL | Buy | ALPHABET INCcap stk cl a | $242,219,000 | +37.0% | 87,087 | +42.7% | 24.45% | +47.4% |
SGMS | SCIENTIFIC GAMES CORP | $157,366,000 | -12.1% | 2,678,571 | 0.0% | 15.88% | -5.5% | |
ABCL | ABCELLERA BIOLOGICS INC | $40,025,000 | -31.8% | 4,105,095 | 0.0% | 4.04% | -26.7% | |
EQRX INC | $21,733,000 | -39.4% | 5,262,161 | 0.0% | 2.19% | -34.9% | ||
PCT | Buy | PURECYCLE TECHNOLOGIES INC | $19,985,000 | +95.2% | 2,498,170 | +133.6% | 2.02% | +109.9% |
RVMD | REVOLUTION MEDICINES INC | $17,101,000 | +1.3% | 670,382 | 0.0% | 1.73% | +9.0% | |
RLAY | RELAY THERAPEUTICS INC | $16,196,000 | -2.5% | 541,124 | 0.0% | 1.64% | +4.8% | |
TXG | 10X GENOMICS INC | $14,160,000 | -48.9% | 186,143 | 0.0% | 1.43% | -45.1% | |
Buy | GRAB HOLDINGS LIMITEDclass a ord | $12,897,000 | -9.6% | 3,684,960 | +84.2% | 1.30% | -2.7% | |
RXRX | RECURSION PHARMACEUTICALS INcl a | $10,806,000 | -58.2% | 1,509,254 | 0.0% | 1.09% | -55.0% | |
MELI KASZEK PIONEER CORPclass a ord | $10,280,000 | -11.1% | 1,000,000 | 0.0% | 1.04% | -4.3% | ||
FULC | FULCRUM THERAPEUTICS INC | $9,713,000 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% | |
ROCKET LAB USA INC | $8,050,000 | -34.4% | 1,000,000 | 0.0% | 0.81% | -29.5% | ||
AFRM | AFFIRM HLDGS INC | $8,032,000 | -54.0% | 173,560 | 0.0% | 0.81% | -50.5% | |
MU | MICRON TECHNOLOGY INC | $7,998,000 | -16.4% | 102,684 | 0.0% | 0.81% | -10.1% | |
PRAX | PRAXIS PRECISION MEDICINES I | $7,949,000 | -48.2% | 778,517 | 0.0% | 0.80% | -44.3% | |
TENAYA THERAPEUTICS INC | $7,931,000 | -37.8% | 673,270 | 0.0% | 0.80% | -33.1% | ||
INTC | INTEL CORP | $7,474,000 | -3.8% | 150,806 | 0.0% | 0.75% | +3.4% | |
NVDA | NVIDIA CORPORATION | $7,180,000 | -7.2% | 26,315 | 0.0% | 0.72% | -0.1% | |
ADI | ANALOG DEVICES INC | $6,894,000 | -6.0% | 41,739 | 0.0% | 0.70% | +1.0% | |
LRCX | LAM RESEARCH CORP | $6,731,000 | -25.2% | 12,521 | 0.0% | 0.68% | -19.6% | |
TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $6,719,000 | -13.3% | 64,443 | 0.0% | 0.68% | -6.9% | |
AMAT | APPLIED MATLS INC | $6,663,000 | -16.2% | 50,553 | 0.0% | 0.67% | -9.9% | |
AMD | ADVANCED MICRO DEVICES INC | $5,971,000 | -24.0% | 54,610 | 0.0% | 0.60% | -18.3% | |
QRVO | QORVO INC | $5,828,000 | -20.7% | 46,963 | 0.0% | 0.59% | -14.7% | |
KNTE | KINNATE BIOPHARMA INC | $5,607,000 | -36.5% | 498,001 | 0.0% | 0.57% | -31.6% | |
TANGO THERAPEUTICS INC | $5,370,000 | -30.7% | 708,385 | 0.0% | 0.54% | -25.4% | ||
CFLT | CONFLUENT INC | $5,346,000 | -46.2% | 130,383 | 0.0% | 0.54% | -42.1% | |
NRIX | NURIX THERAPEUTICS INC | $4,410,000 | -51.6% | 314,762 | 0.0% | 0.44% | -48.0% | |
PLRX | PLIANT THERAPEUTICS INC | $3,942,000 | -48.1% | 562,379 | 0.0% | 0.40% | -44.2% | |
SANA | SANA BIOTECHNOLOGY INC | $3,872,000 | -46.6% | 468,749 | 0.0% | 0.39% | -42.6% | |
GBIO | GENERATION BIO CO | $3,746,000 | +3.7% | 510,354 | 0.0% | 0.38% | +11.5% | |
XILIO THERAPEUTICS INC | $2,942,000 | -55.8% | 416,059 | 0.0% | 0.30% | -52.5% | ||
PARDES BIOSCIENCES INC | $2,888,000 | -55.9% | 400,000 | 0.0% | 0.29% | -52.5% | ||
SURROZEN INC | $2,489,000 | -53.3% | 826,852 | 0.0% | 0.25% | -49.8% | ||
PACB | PACIFIC BIOSCIENCES CALIF IN | $2,085,000 | -55.5% | 229,144 | 0.0% | 0.21% | -52.3% | |
PCTTW | New | PURECYCLE TECHNOLOGIES INC*w exp 03/17/202 | $2,050,000 | – | 714,285 | +100.0% | 0.21% | – |
New | VIGIL NEUROSCIENCE INC | $2,035,000 | – | 289,460 | +100.0% | 0.20% | – | |
DYN | DYNE THERAPEUTICS INC | $1,034,000 | -18.9% | 107,252 | 0.0% | 0.10% | -13.3% | |
DBTX | DECIBEL THERAPEUTICS INC | $1,000,000 | -34.6% | 328,798 | 0.0% | 0.10% | -29.9% | |
MGTA | MAGENTA THERAPEUTICS INC | $965,000 | -34.5% | 332,610 | 0.0% | 0.10% | -29.7% | |
MCRB | SERES THERAPEUTICS INC | $939,000 | -14.5% | 131,847 | 0.0% | 0.10% | -7.8% | |
GMTX | GEMINI THERAPEUTICS INC | $348,000 | -52.2% | 250,000 | 0.0% | 0.04% | -48.5% | |
Exit | SURROZEN INC*w exp 08/01/203 | $0 | – | -108,333 | -100.0% | -0.01% | – | |
DADA | Exit | DADA NEXUS LTDads | $0 | – | -40,338 | -100.0% | -0.05% | – |
ASML | Exit | ASML HOLDING N V | $0 | – | -9,034 | -100.0% | -0.68% | – |
RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -3,464,990 | -100.0% | -12.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 34 | Q3 2021 | 19.4% |
VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
ISHARES TR | 34 | Q3 2021 | 4.9% |
META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
ALPHABET INC | 19 | Q3 2023 | 30.4% |
ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.